VU0652925 is a PAR4 antagonist. VU0652925 had a PAC1 IC50 of 43.0 pM (-pIC50± 10.4±0.04) and a P-sel IC50 of 39.2 pM (-pIC50± 10.41±0.04). PAR4 antagonists is potential useful for the development of tools such as radioligands and PET tracers that are not currently available to the field for this target. References:

纯度：≥98%

CAS：1476847-58-1